Cystic Fibrosis Drugs Market Report

China Cystic Fibrosis Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 16, 2023
  • PAGES：208
  • REPORT CODE：GMM1800640
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Cystic Fibrosis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • PTC Therapeutics

    • Novartis

    • Pharmaxis

    • United Medical

    • Corbus Pharmaceuticals

    • Merck Sharp & Dohme

    • Johnson & Johnson

    • Vertex Pharmaceuticals

    • Venus Remedies

    • Proteostasis Therapeutics

    • Gilead Sciences

    • Actavis

    • Arcturus Therapeutics

    • PharmaSwiss

    • Anthera Pharmaceuticals

    • Neovii Biotech

    • Abbott

    • Insmed

    • Boehringer Ingelheim

    • Novo Nordisk

    By Type:

    • Injection

    • Oral

    By Application:

    • Hospital

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cystic Fibrosis Drugs Market Overview 2018-2029

    • 1.1 China Cystic Fibrosis Drugs Industry Development Overview

    • 1.2 China Cystic Fibrosis Drugs Industry Development History

    • 1.3 China Cystic Fibrosis Drugs Industry Market Size (2018-2029)

    • 1.4 China Cystic Fibrosis Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Cystic Fibrosis Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

      • 1.4.2 China Cystic Fibrosis Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • 1.5 China Cystic Fibrosis Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Cystic Fibrosis Drugs Market Analysis by Region

      • 1.6.1 North China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cystic Fibrosis Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cystic Fibrosis Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cystic Fibrosis Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Cystic Fibrosis Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cystic Fibrosis Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cystic Fibrosis Drugs Industry Development

    Chapter 3 Cystic Fibrosis DrugsIndustry Chain Analysis

    • 3.1 Cystic Fibrosis Drugs Industry Chain

    • 3.2 Cystic Fibrosis Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cystic Fibrosis Drugs Market

    • 3.3 Cystic Fibrosis Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cystic Fibrosis Drugs Market

    Chapter 4 China Cystic Fibrosis Drugs Market, by Type

    • 4.1 China Cystic Fibrosis Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cystic Fibrosis Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cystic Fibrosis Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Cystic Fibrosis Drugs Production Volume and Growth Rate of Injection

      • 4.5.2 China Cystic Fibrosis Drugs Production Volume and Growth Rate of Oral

    Chapter 5 China Cystic Fibrosis Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cystic Fibrosis Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cystic Fibrosis Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Cystic Fibrosis Drugs Market Size and Growth Rate of Hospital

      • 5.5.2 China Cystic Fibrosis Drugs Market Size and Growth Rate of Clinic

    Chapter 6 China Cystic Fibrosis Drugs Market, by Region

    • 6.1 China Cystic Fibrosis Drugs Production Volume and Production Value, by Region

    • 6.2 China Cystic Fibrosis Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Cystic Fibrosis Drugs Market Analysis

    • 7.1 North China Cystic Fibrosis Drugs Market, by Type

    • 7.2 North China Cystic Fibrosis Drugs Market, by Application

    Chapter 8 Central China Cystic Fibrosis Drugs Market Analysis

    • 8.1 Central China Cystic Fibrosis Drugs Market, by Type

    • 8.2 Central China Cystic Fibrosis Drugs Market, by Application

    Chapter 9 South China Cystic Fibrosis Drugs Market Analysis

    • 9.1 South China Cystic Fibrosis Drugs Market, by Type

    • 9.2 South China Cystic Fibrosis Drugs Market, by Application

    Chapter 10 East China Cystic Fibrosis Drugs Market Analysis

    • 10.1 East China Cystic Fibrosis Drugs Market, by Type

    • 10.2 East China Cystic Fibrosis Drugs Market, by Application

    Chapter 11 Northeast China Cystic Fibrosis Drugs Market Analysis

    • 11.1 Northeast China Cystic Fibrosis Drugs Market, by Type

    • 11.2 Northeast China Cystic Fibrosis Drugs Market, by Application

    Chapter 12 Southwest China Cystic Fibrosis Drugs Market Analysis

    • 12.1 Southwest China Cystic Fibrosis Drugs Market, by Type

    • 12.2 Southwest China Cystic Fibrosis Drugs Market, by Application

    Chapter 13 Northwest China Cystic Fibrosis Drugs Market Analysis

    • 13.1 Northwest China Cystic Fibrosis Drugs Market, by Type

    • 13.2 Northwest China Cystic Fibrosis Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 PTC Therapeutics

        • 14.1.1 PTC Therapeutics Company Profile

        • 14.1.2 PTC Therapeutics Cystic Fibrosis Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis

        • 14.2.1 Novartis Company Profile

        • 14.2.2 Novartis Cystic Fibrosis Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pharmaxis

        • 14.3.1 Pharmaxis Company Profile

        • 14.3.2 Pharmaxis Cystic Fibrosis Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 United Medical

        • 14.4.1 United Medical Company Profile

        • 14.4.2 United Medical Cystic Fibrosis Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Corbus Pharmaceuticals

        • 14.5.1 Corbus Pharmaceuticals Company Profile

        • 14.5.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck Sharp & Dohme

        • 14.6.1 Merck Sharp & Dohme Company Profile

        • 14.6.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Johnson & Johnson

        • 14.7.1 Johnson & Johnson Company Profile

        • 14.7.2 Johnson & Johnson Cystic Fibrosis Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Vertex Pharmaceuticals

        • 14.8.1 Vertex Pharmaceuticals Company Profile

        • 14.8.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Venus Remedies

        • 14.9.1 Venus Remedies Company Profile

        • 14.9.2 Venus Remedies Cystic Fibrosis Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Proteostasis Therapeutics

        • 14.10.1 Proteostasis Therapeutics Company Profile

        • 14.10.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Gilead Sciences

        • 14.11.1 Gilead Sciences Company Profile

        • 14.11.2 Gilead Sciences Cystic Fibrosis Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Actavis

        • 14.12.1 Actavis Company Profile

        • 14.12.2 Actavis Cystic Fibrosis Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Arcturus Therapeutics

        • 14.13.1 Arcturus Therapeutics Company Profile

        • 14.13.2 Arcturus Therapeutics Cystic Fibrosis Drugs Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 PharmaSwiss

        • 14.14.1 PharmaSwiss Company Profile

        • 14.14.2 PharmaSwiss Cystic Fibrosis Drugs Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Anthera Pharmaceuticals

        • 14.15.1 Anthera Pharmaceuticals Company Profile

        • 14.15.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Neovii Biotech

        • 14.16.1 Neovii Biotech Company Profile

        • 14.16.2 Neovii Biotech Cystic Fibrosis Drugs Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Abbott

        • 14.17.1 Abbott Company Profile

        • 14.17.2 Abbott Cystic Fibrosis Drugs Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Insmed

        • 14.18.1 Insmed Company Profile

        • 14.18.2 Insmed Cystic Fibrosis Drugs Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Boehringer Ingelheim

        • 14.19.1 Boehringer Ingelheim Company Profile

        • 14.19.2 Boehringer Ingelheim Cystic Fibrosis Drugs Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Novo Nordisk

        • 14.20.1 Novo Nordisk Company Profile

        • 14.20.2 Novo Nordisk Cystic Fibrosis Drugs Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cystic Fibrosis Drugs Industry Research Conclusions

    • 15.2 Cystic Fibrosis Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cystic Fibrosis Drugs Industry Market Size (2018-2029)

    • Figure China Cystic Fibrosis Drugs Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China Cystic Fibrosis Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)

    • Figure China Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cystic Fibrosis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Cystic Fibrosis Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cystic Fibrosis Drugs Market Share by Type in 2018

    • Figure China Cystic Fibrosis Drugs Market Share by Type in 2023

    • Figure China Cystic Fibrosis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cystic Fibrosis Drugs Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China Cystic Fibrosis Drugs Production Volume and Growth Rate of Oral (2018-2023)

    • Figure China Cystic Fibrosis Drugs Market Share by Application in 2018

    • Figure China Cystic Fibrosis Drugs Market Share by Application in 2023

    • Figure China Cystic Fibrosis Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Cystic Fibrosis Drugs Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Cystic Fibrosis Drugs Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Cystic Fibrosis Drugs Production Volume by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Production Volume Share by Region (2018-2023)

    • Figure China Cystic Fibrosis Drugs Production Volume Share by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Production Value by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Production Value Share by Region (2018-2023)

    • Figure China Cystic Fibrosis Drugs Production Value Share by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Sales Volume by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Cystic Fibrosis Drugs Sales Volume Share by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Sales Value by Region (2018-2023)

    • Table China Cystic Fibrosis Drugs Sales Value Share by Region (2018-2023)

    • Figure China Cystic Fibrosis Drugs Sales Value Share by Region (2018-2023)

    • Table North China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table North China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table North China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table North China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table Central China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table Central China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table South China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table South China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table South China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table East China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table East China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table East China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cystic Fibrosis Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cystic Fibrosis Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Cystic Fibrosis Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cystic Fibrosis Drugs Sales Volume Share by Application (2018-2023)

    • Table PTC Therapeutics Company Profile

    • Table PTC Therapeutics Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Pharmaxis Company Profile

    • Table Pharmaxis Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table United Medical Company Profile

    • Table United Medical Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Corbus Pharmaceuticals Company Profile

    • Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Sharp & Dohme Company Profile

    • Table Merck Sharp & Dohme Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Vertex Pharmaceuticals Company Profile

    • Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Venus Remedies Company Profile

    • Table Venus Remedies Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Proteostasis Therapeutics Company Profile

    • Table Proteostasis Therapeutics Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Actavis Company Profile

    • Table Actavis Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Arcturus Therapeutics Company Profile

    • Table Arcturus Therapeutics Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table PharmaSwiss Company Profile

    • Table PharmaSwiss Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Anthera Pharmaceuticals Company Profile

    • Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Neovii Biotech Company Profile

    • Table Neovii Biotech Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Insmed Company Profile

    • Table Insmed Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Cystic Fibrosis Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US